MarkWide Research

Sale!

Scar Treatment Market Analysis- Industry Size, Share, Research Report, Insights, Covid-19 Impact, Statistics, Trends, Growth and Forecast 2022-2030

Published Date: August, 2022
No of Pages: 172
Delivery Format: PDF + Excel

$2,950.00

Report Overview

The market for scar treatments in the world size was estimated at USD 12.3 billion as of 2020. It is predicted to grow by a compound annual growth percentage (CAGR) in the range of 10.1 per cent from 2021 until 2028. The market is driven by the rising demand to improve the appearance of people and for total cosmetic rejuvenation of the skin. Women are the primary source of direction since they are more conscious of their arrival. The rising number of road accidents and burn injuries has caused a rise in cosmetic surgeries internationally. An increase in the number of hypertrophic burns, in which the appearance of the victims has become disfigured, is also driving sales of scar treatment products.

The initial two phases of the COVID-19 pandemic were characterized by the rapid growth of telemedicine across all aspects of healthcare. Skincare, as a non-urgent issue, needs only minimal hospital visits. Although final procedures require a patient to go to the hospital or doctor’s office for pre-planning, post-procedure management and even post-surgical planning are facilitated mainly by telemedicine. COVID-19 has impeded the growth of the market until 2020. Still, the developments in the field of telemedicine are likely to play an essential role in optimizing the growth of the market in comparison to non-covid scenarios. Additionally, the introduction of ambulatory surgery centres and the creation of mobile or portable devices for treating scars are expected to accelerate the market’s growth in both developed and developing regions.

The increasing number of road-related accidents is a high-impact rendering factor, which is driving the demand for scar-treatment products. Based on the Population Reference Bureau, around 50 million people get injured as a result of accidents on the road every year. This frequently results in the formation of scars that require surgical treatment. Patients who undergo surgery have spots and are given topical remedies to help improve and lessen their appearance. Thus, the growing number of accidents on the road and the growing number of cosmetic procedures will likely increase the demand for topical products to treat scars.

According to the Plastic Surgery Statistics Report, 181,132 procedures for scar revision were completed in 2019, making it among the top five reconstructive procedures. Therefore, the need for improved aesthetics is a significant factor in the increase in reconstructive surgical procedures for scar revision. Alongside skin correction operations, scar treatments are also popularly used.

Product Insights

Topical products had the highest part of 58.0 per cent in 2020. The availability of creams, gels, topical gels and silicone sheets over the counter (OTC) products allows people to use these products to treat wounds. Lasers are also utilized extensively since they offer a non-invasive and painless option for treating scars that cause minimal discomfort.

These products are applied directly to the skin. They are classified into gels, creams, silicone sheets, and others. Because these products are readily available to customers as OTC products and are frequently purchased. Furthermore, treatment with these products does not depend on people visiting a physician to get medication, so they are an easy alternative that is predicted to increase the popularity of these items.

Other topical products are pressure-wearing items like elastic bandages, oils sprays and Ointments. Pressure-sensitive clothing applies pressure to the site of the scar to treat the spot. They are not invasive and can be involved at home with no medical consultation. However, these products for topical use are less effective and need about 6-12 months of continuous service to achieve visible results. This could slow growth in the market over the forecast time.

Report Coverage & Deliverables

PDF report & online dashboard will help you understand:

  • Competitive benchmarking
  • Historical data and forecasts
  • Revenue shares of the company
  • Opportunities for regional development
  • Latest trends & dynamics

Scar Type Insights

Atrophic scars accounted for the highest portion of 36.4 per cent in 2020 due to the increasing prevalence of acne-related spots. They are typically treated using topical creams and gels. Keloid and hypertrophic scars are expected to see significant growth in the coming period due to their joint appearance in people suffering from wounds.

Atrophic scars are typically the result of losing fat and muscle mass from the body on an area that has been injured. Atrophic scars usually develop because the skin does not produce enough collagen to heal an infection. The kind of scar that forms resemble an open pit and is typically caused by acne, staphylococcus infections, chickenpox and, in some instances, surgical intervention.

The treatment for these scars is usually centered around applying gels, creams, and ointments that are topical and readily available. The treatment applied to these scars aids in stimulating the skin’s healing process to replace collagen, elastin, and other fibrous tissue. This allows the skin of the healing lesion to expand around the surrounding area. Since most of the marks are caused by acne, using these creams will enable the appearance of the spots to diminish. In addition, due to the increasing demands for aesthetics and a more attractive appearance, the need for creams for treating atrophic scars are growing.

End-use Insights

The hospital’s segment led the market with a market share of 43.0 per cent by 2020 due to the utilization of high-tech infrastructure and advanced technology in these environments to treat scars. The retail pharmacies/e-commerce segment is projected to witness the fastest growth over the forecast period due to the rapid growth of online websites and easy access to scar treatment products on these websites. The emergence of COVID-19 is also anticipated to accelerate the development of the e-commerce market.

Most treatments for scars are offered at hospitals, allowing patients to select from various options for reducing or eliminating the spot. Hospitals offer patients emergency treatment in most cases involving burns, cuts, wounds, and other serious injuries. The treatment procedure is also provided by hospitals, as they work to reduce the formation of scars for patients. Hospitals regularly usually have various high-tech equipment and advanced techniques for treating patients. Utilizing non-invasive methods like creams, gels and silicone sheets with laser therapy is common in hospitals.

Hospitals offer comprehensive treatment for the majority of emergency services. They also provide care throughout the healing process. Specialized care is given to patients in many burns to aid the healing process. The primary consideration is offered to most of the world’s hospital patients, thereby being the most significant player in the market.

Regional Insights

North America dominated the market with a share of 35.2 per cent in 2020 due to the general population’s high level of aesthetic awareness and the rapid adoption of technologically advanced products. Additionally, the most advanced instruments for treating scars are highly sought-after within the U.S.

In 2020, the U.S. held the most significant part of this North American market 2020. As per the American Burn Association (ABA), there are around 486,000 cases of burns annually. The treatment for burn injuries is covered by the reimbursement policies of the government in the U.S. Treatment for scars caused by acne will not be covered until a Letter of Medical Necessity is provided by a medical expert. The rising cost of healthcare for patients is a significant factor driving scar treatment in the U.S. market. Due to the above elements, the U.S. market for scar treatment is anticipated to see an increase in growth. Sonoma Pharmaceuticals; Cynosure, Inc.; CCA Industries, Inc. And Scar Heal, Inc. are among the leading participants in Scar Heal, Inc.’s U.S. market.

Asia Pacific is expected to show the most significant CAGR of 11.4 per cent during the forecast time frame due to the high rate of road accidents in nations like India. The key countries of Asia Pacific are Asia Pacific market is India and China. Most of the nations in this region are emerging economies and are advancing towards more rapid adoption of technological advances. The increased investment of major multinational corporations in R&D across these regions has been proven to be an important reason behind the growth of industries in this region. The rise in proportion of women conscious of their appearance has grown dramatically, which is expected to propel the market within the area.

Key Companies & Market Share Insights

The market leaders are forming strategic alliances to broaden their product offerings in scar treatments. For example, in December 2020, Molnlycke Healthcare opened a new distribution center in Northampton shire in the U.K. This distribution center was planned to guarantee uninterrupted product supply across all of the U.K. with prevailing supply uncertain by Brexit as well as COVID-19. The most prominent players in the market for scar treatment include:

  • Smith & Nephew PLC
  • Lumenis
  • Merz Pharmaceuticals, LLC
  • Sonoma Pharmaceuticals, Inc.
  • Cynosure
  • CCA Industries, Inc.
  • New medical Technology Inc.
  • Molnlycke Health Care AB
  • Suneva Medical

Scar Treatment Market Report Scope

Report AttributeDetails
Market size value in 2021USD 23.6 billion
Revenue forecast in 2028USD 46.3 billion
Growth rateCAGR of 10.1% from 2021 to 2028
Base year for estimation2020
Historical data2017 – 2021
Forecast period2022 – 2030
Quantitative unitsRevenue in USD million/billion and CAGR from 2021 to 2028
Report coverageRevenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments coveredProduct, scar type, end-use, region
Regional scopeNorth America; Europe; Asia Pacific; Latin America; MEA
Country scopeU.S.; Canada; U.K.; Germany; France; Italy; Spain; Russia; India; Japan; China; Singapore; South Korea; Australia; Brazil; Mexico; Argentina; South Africa; Saudi Arabia; UAE
Key companies profiledSmith & Nephew PLC; Lumenis; Merz Pharmaceuticals, LLC; Sonoma Pharmaceuticals, Inc.; Cynosure; CCA Industries, Inc.; New medical Technology Inc.; Molnlycke Health Care AB; Suneva Medical
Customization scopeFree report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase optionsAvail customized purchase options to meet your exact research needs.

Segments Covered in the Report

The report predicts growth in revenue at the regional, global and country levels. It analyses current trends and opportunities within every segment between 2016 and 2028. To make this report, Grand View Research has classified the market for global scar treatment report based on the type of product, scar type end-use, scar type and the region in which it is located:

  • Product Outlook 
  • Topical Products
      • Creams
      • Gels
      • Silicon Sheets
    • Others
  • Laser Products
      • CO2Laser
      • Pulse-dyed Laser
    • Others
    • Injectables
    • Others
  • Scar Type Outlook 
    • Atrophic Scars
    • Hypertrophic and Keloid Scars
    • Contracture Scars
    • Stretch Marks
  • End-use Outlook 
    • Hospitals
    • Clinics
    • Retail Pharmacies/ E-commerce

Regional Analysis

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • Italy
    • France
    • UK
    • Spain
    • Poland
    • Russia
    • The Netherlands
    • Norway
    • Czech Republic
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Indonesia
    • Malaysia
    • Thailand
    • Singapore
    • Australia & New Zealand
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Colombia
    • Rest of South America
  • The Middle East & Africa
    • Saudi Arabia
    • UAE
    • South Africa
    • Northern Africa
    • Rest of MEA

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Product
1.1.2. Scar Type
1.1.3. End Use
1.1.4. Regional Scope
1.1.5. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVRs internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.3.5.1. Data for primary interviews in North America
1.3.5.2. Data for primary interviews in Europe
1.3.5.3. Data for primary interviews in Asia Pacific
1.3.5.4. Data for primary interviews in Latin America
1.3.5.5. Data for Primary interviews in MEA
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.6.2. Volume price analysis (Model 2)
1.6.2.1. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
2.3 Competitive Insights
Chapter 3 Scar Treatment Market Variables, Trends & Scope
3.1 Market Lineage Outlook
3.1.1 Parent Market Outlook
3.1.2 Ancillary Market Outlook
3.2 Penetration and Growth Prospect Mapping
3.3 Product Pipeline Analysis, by Stage
3.4 Industry Analysis
3.4.1 Cost structure analysis
3.4.2 User perspective analysis
3.4.2.1 Consumer behavior analysis
3.4.2.2 Market influencer analysis
3.4.3 Cost analysis breakdown
3.4.4 List of key end users, by region
3.5 Technology Overview
3.5.1 Technology timeline
3.6 Regulatory Framework
3.6.1 Reimbursement framework
3.6.2 Standards and compliances
3.7 Market Dynamics
3.7.1 Market driver analysis
3.7.1.1 Growing demand for aesthetics
3.7.1.2 Growing number of road accidents and burn cases
3.7.1.3 Growing technological advancements
3.7.2 Market Restraint Analysis
3.7.2.1 High cost of laser-based products
3.7.3 Industry challenges
3.7.3.1 Presence of ambiguous regulatory framework
3.8 Scar Treatment Market Analysis tools
3.8.1 Industry analysis – Porters
3.8.1.1 Supplier Power
3.8.1.2 Buyer Power
3.8.1.3 Substitution Threat
3.8.1.4 Threat from new entrants
3.8.1.5 Competitive Rivalry
3.8.2 PESTEL Analysis
3.8.2.1 Political Landscape
3.8.2.2 Environmental Landscape
3.8.2.3 Social landscape
3.8.2.4 Technology landscape
3.8.2.5 Legal Landscape
3.8.3 Major deals and strategic alliances analysis
3.8.3.1 Joint ventures
3.8.3.2 Mergers and acquisitions
3.8.3.3 Licensing and partnership
3.8.3.4 Technology collaborations
3.8.3.5 Strategic Divestments
3.8.4 Market entry strategies
3.8.5 Case Studies
Chapter 4 Scar Treatment Market – Competitive Analysis
4.1 Recent Developments & Impact Analysis, by Key Market Participants
4.2 Company Categorization
4.3 Vendor Landscape
4.3.1 List of key distributors and channel partners
4.3.2 Key customers
4.3.3 Key company market share analysis, 2020
4.4 Public Companies
4.4.1 Company market position analysis
4.4.2 Company market share, by region
4.4.3 Competitive dashboard analysis
4.4.3.1 Market differentiators
4.4.3.2 Synergy analysis: Major deals and strategic alliances
4.5 Private Companies
4.5.1 List of key emerging companies
4.5.2 Regional network map
4.5.3 Company market position analysis
4.5.4 Supplier ranking
Chapter 5 Scar Treatment Market: Product Estimates And Trend Analysis
5.1 Definition & Scope
5.2 Product Market Share Analysis, 2020 & 2028
5.3 Segment Dashboard
5.4 Global Scar Treatment Market, by Product, 2016 – 2028
5.5 Market Size & Forecasts and Trend Analyses, 2016 – 2028
5.5.1 Topical Products
5.5.1.1 Creams
5.5.1.1.1 Creams Market, 2016 – 2028 (USD Million)
5.5.1.2 Gels
5.5.1.2.1 Gels Market, 2016 – 2028 (USD Million)
5.5.1.3 Silicon Sheets
5.5.1.3.1 Silicon Sheets Market, 2016 – 2028 (USD Million)
5.5.1.4 Other topical Products
5.5.1.4.1 Other Tropical Products Market, 2016 – 2028 (USD Million)
5.5.2 Laser Products
5.5.2.1 CO2 Laser
5.5.2.1.1 CO2 Laser Market, 2016 – 2028 (USD Million)
5.5.2.2 Pulse-Dyed Laser
5.5.2.2.1 Pulse-Dyed Laser Market, 2016 – 2028 (USD Million)
5.5.2.3 Other Laser Products
5.5.2.3.1 Other Laser Products Market, 2016 – 2028 (USD Million)
5.5.3 Injectables
5.5.3.1 Injectables Market, 2016 – 2028 (USD Million)
5.5.4 Others
5.5.4.1 Other Products Market, 2016 – 2028 (USD Million)
Chapter 6 Scar Treatment Market: Scar Type Estimates And Trend Analysis
6.1 Definition & Scope
6.2 Scar Type Market Share Analysis, 2020 & 2028
6.3 Segment Dashboard
6.4 Global Scar Treatment Market, By Scar Type, 2016 – 2028
6.5 Market Size & Forecasts And Trend Analyses, 2016 – 2028
6.5.1 Atrophic Scars
6.5.1.1 Atrophic Scars Market, 2016 – 2028 (USD Million)
6.5.1.2 Atrophic Scars Market, By Product, 2016 – 2028 (USD Million)
6.5.2 Hypertrophic And Keloid Scars
6.5.2.1 Hypertrophic And Keloid Scars Market, 2016 – 2028 (USD Million)
6.5.2.2 Hypertrophic And Keloid Scars Market, By Product, 2016 – 2028 (USD Million)
6.5.3 Contracture Scars
6.5.3.1 Contracture Scars Market, 2016 – 2028 (USD Million)
6.5.3.2 Contracture Scars Market, By Product, 2016 – 2028 (USD Million)
6.5.4 Stretch Marks
6.5.4.1 Stretch Marks Market, 2016 – 2028 (USD Million)
6.5.4.2 Stretch Marks Market, By Product, 2016 – 2028 (USD Million)
Chapter 7 Scar Treatment Market: End-use Estimates And Trend Analysis
7.1 Definition & Scope
7.2 End-use Market Share Analysis, 2020 & 2028
7.3 Segment Dashboard
7.4 Global Scar Treatment Market, By End Use, 2016 – 2028
7.5 Market Size & Forecasts And Trend Analyses, 2016 – 2028
7.5.1 Hospitals
7.5.1.1 Hospitals Market, 2016 – 2028 (USD Million)
7.5.2 Clinics
7.5.2.1 Clinics Market, 2016 – 2028 (USD Million)
7.5.3 Retail Pharmacies/E-commerce
7.5.3.1 Retail Pharmacies/E-commerce Market, 2016 – 2028 (USD Million)
Chapter 8 Scar Treatment Market: Regional Estimates & Trend Analysis
8.1 Regional Market Snapshot
8.2 Regional Market Share and Leading Players, 2020
8.2.1 North America
8.2.2 Europe
8.2.3 Latin America
8.2.4 Asia Pacific
8.2.5 Middle East & Africa
8.3 Market Share Analysis by Country, 2020
8.3.1 North America
8.3.1.1 U.S.
8.3.1.2 Canada
8.3.2 Europe
8.3.2.1 U.K.
8.3.2.2 Germany
8.3.2.3 Spain
8.3.2.4 France
8.3.2.5 Italy
8.3.2.6 Russia
8.3.3 Latin America
8.3.3.1 Brazil
8.3.3.2 Mexico
8.3.3.3 Argentina
8.3.4 Asia Pacific
8.3.4.1 Japan
8.3.4.2 China
8.3.4.3 India
8.3.4.4 South Korea
8.3.4.5 Singapore
8.3.4.6 Australia
8.3.5 Middle east & Africa
8.3.5.1 South Africa
8.3.5.2 Saudi Arabia
8.3.5.3 UAE
8.4 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
8.4.1 North America
8.4.2 Europe
8.4.3 Latin America
8.4.4 Asia Pacific
8.4.5 Middle East & Africa
8.5 Market Size & Forecasts, and Trend Analysis, 2020 to 2028
8.5.1 North America
8.5.1.1 North America Market, 2016 – 2028 (USD Million)
8.5.1.2 U.S.
8.5.1.2.1 U.S. Market, 2016 – 2028 (USD Million)
8.5.1.3 Canada
8.5.1.3.1 Canada Market, 2016 – 2028 (USD Million)
8.5.2 Europe
8.5.2.1 Europe Market, 2016 – 2028 (USD Million)
8.5.2.2 U.K.
8.5.2.2.1 U.K. Market, 2016 – 2028 (USD Million)
8.5.2.3 Germany
8.5.2.3.1 Germany Market, 2016 – 2028 (USD Million)
8.5.2.4 Spain
8.5.2.4.1 Spain Market, 2016 – 2028 (USD Million)
8.5.2.5 France
8.5.2.5.1 France Market, 2016 – 2028 (USD Million)
8.5.2.6 Italy
8.5.2.6.1 Italy Market, 2016 – 2028 (USD Million)
8.5.2.7 Russia
8.5.2.7.1 Russia Market, 2016 – 2028 (USD Million)
8.5.3 Latin America
8.5.3.1 Latin America Market, 2016 – 2028 (USD Million)
8.5.3.2 Brazil
8.5.3.2.1 Brazil Market, 2016 – 2028 (USD Million)
8.5.3.3 Mexico
8.5.3.3.1 Mexico Market, 2016 – 2028 (USD Million)
8.5.3.4 Argentina
8.5.3.4.1 Argentina Market, 2016 – 2028 (USD Million)
8.5.4 Asia Pacific
8.5.4.1 Asia Pacific Market, 2016 – 2028 (USD Million)
8.5.4.2 Japan
8.5.4.2.1 Japan Market, 2016 – 2028 (USD Million)
8.5.4.3 China
8.5.4.3.1 China Market, 2016 – 2028 (USD Million)
8.5.4.4 India
8.5.4.4.1 India Market, 2016 – 2028 (USD Million)
8.5.4.5 South Korea
8.5.4.5.1 South Korea Market, 2016 – 2028 (USD Million)
8.5.4.6 Singapore
8.5.4.6.1 Singapore Market, 2016 – 2028 (USD Million)
8.5.4.7 Australia
8.5.4.7.1 Australia Market, 2016 – 2028 (USD Million)
8.5.5 Middle East & Africa
8.5.5.1 Middle East & Africa Market, 2016 – 2028 (USD Million)
8.5.5.2 South Africa
8.5.5.2.1 South Africa Market, 2016 – 2028 (USD Million)
8.5.5.3 Saudi Arabia
8.5.5.3.1 Saudi Arabia Market, 2016 – 2028 (USD Million)
8.5.5.4 UAE
8.5.5.4.1 UAE Market, 2016 – 2028 (USD Million)
Chapter 9 Company Profile
9.1 Company Profiles
9.1.1 Smith & Nephew
9.1.1.1 Company overview
9.1.1.2 Financial Performance
9.1.1.3 Product benchmarking
9.1.1.4 Strategic initiatives
9.1.2 Merz North America, Inc.
9.1.2.1 Company overview
9.1.2.2 Financial Performance
9.1.2.3 Product benchmarking
9.1.2.4 Strategic initiatives
9.1.3 LUMENIS
9.1.3.1 Company overview
9.1.3.2 Financial Performance
9.1.3.3 Product benchmarking
9.1.3.4 Strategic initiatives
9.1.4 Enaltus LLC
9.1.4.1 Company overview
9.1.4.2 Financial Performance
9.1.4.3 Product benchmarking
9.1.4.4 Strategic initiatives
9.1.5 Sonoma Pharmaceuticals, Inc.
9.1.5.1 Company overview
9.1.5.2 Financial Performance
9.1.5.3 Product benchmarking
9.1.5.4 Strategic initiatives
9.1.6 Mlnlycke Health Care
9.1.6.1 Company overview
9.1.6.2 Financial Performance
9.1.6.3 Product benchmarking
9.1.6.4 Strategic initiatives
9.1.7 Cynosure, Inc.
9.1.7.1 Company overview
9.1.7.2 Financial Performance
9.1.7.3 Product benchmarking
9.1.7.4 Strategic initiatives
9.1.8 CCA Industries, Inc.
9.1.8.1 Company overview
9.1.8.2 Financial Performance
9.1.8.3 Product benchmarking
9.1.8.4 Strategic initiatives
9.1.9 Scar Heal Inc.
9.1.9.1 Company overview
9.1.9.2 Financial Performance
9.1.9.3 Product benchmarking
9.1.9.4 Strategic initiatives
9.1.10 Newmedical Technology
9.1.10.1 Company overview
9.1.10.2 Financial Performance
9.1.10.3 Product benchmarking
9.1.10.4 Strategic initiatives
9.1.11 Suneva Medical Inc.
9.1.11.1 Company overview
9.1.11.2 Financial Performance
9.1.11.3 Product benchmarking
9.1.11.4 Strategic initiatives
9.1.12 Pacific World Corporation
9.1.12.1 Company overview
9.1.12.2 Financial Performance
9.1.12.3 Product benchmarking
9.1.12.4 Strategic initiatives
9.1.13 Perrigo Company plc
9.1.13.1 Company overview
9.1.13.2 Financial Performance
9.1.13.3 Product benchmarking
9.1.13.4 Strategic initiatives

List of Tables

Table 1 List of key distributors and channel partners
Table 2 List of key emerging companies/technology disruptors/innovators
Table 3 North America scar treatment market, by country, 2016 – 2028 (USD Million)
Table 4 North America scar treatment market, by product, 2016 – 2028 (USD Million)
Table 5 North America topical products market, by type, 2016 – 2028 (USD Million)
Table 6 North America laser products market, by type, 2016 – 2028 (USD Million)
Table 7 North America scar treatment market, by scar type, 2016 – 2028 (USD Million)
Table 8 North America atrophic scar treatment market, by product, 2016 – 2028 (USD Million)
Table 9 North America hypertrophic and keloid scar treatment market, by product, 2016 – 2028 (USD Million)
Table 10 North America contracture scar treatment market, by product, 2016 – 2028 (USD Million)
Table 11 North America stretch marks market, by product, 2016 – 2028 (USD Million)
Table 12 North America scar treatment market, by end use, 2016 – 2028 (USD Million)
Table 13 U.S. scar treatment market, by product, 2016 – 2028 (USD Million)
Table 14 U.S. topical products market, by type, 2016 – 2028 (USD Million)
Table 15 U.S. laser products market, by type, 2016 – 2028 (USD Million)
Table 16 U.S. scar treatment market, by scar type, 2016 – 2028 (USD Million)
Table 17 U.S. atrophic scar treatment market, by product, 2016 – 2028 (USD Million)
Table 18 U.S. hypertrophic and keloid scar treatment market, by product, 2016 – 2028 (USD Million)
Table 19 U.S. contracture scar treatment market, by product, 2016 – 2028 (USD Million)
Table 20 U.S. stretch marks market, by product, 2016 – 2028 (USD Million)
Table 21 U.S. scar treatment market, by end use, 2016 – 2028 (USD Million)
Table 22 Canada scar treatment market, by product, 2016 – 2028 (USD Million)
Table 23 Canada topical products market, by type, 2016 – 2028 (USD Million)
Table 24 Canada laser products market, by type, 2016 – 2028 (USD Million)
Table 25 Canada scar treatment market, by scar type, 2016 – 2028 (USD Million)
Table 26 Canada atrophic scar treatment market, by product, 2016 – 2028 (USD Million)
Table 27 Canada hypertrophic and keloid scar treatment market, by product, 2016 – 2028 (USD Million)
Table 28 Canada contracture scar treatment market, by product, 2016 – 2028 (USD Million)
Table 29 Canada stretch marks market, by product, 2016 – 2028 (USD Million)
Table 30 Canada scar treatment market, by end use, 2016 – 2028 (USD Million)
Table 31 Europe scar treatment market, by country, 2016 – 2028 (USD Million)
Table 32 Europe scar treatment market, by product, 2016 – 2028 (USD Million)
Table 33 Europe topical products market, by type, 2016 – 2028 (USD Million)
Table 34 Europe laser products market, by type, 2016 – 2028 (USD Million)
Table 35 Europe scar treatment market, by scar type, 2016 – 2028 (USD Million)
Table 36 Europe atrophic scar treatment market, by product, 2016 – 2028 (USD Million)
Table 37 Europe hypertrophic and keloid scar treatment market, by product, 2016 – 2028 (USD Million)
Table 38 Europe contracture scar treatment market, by product, 2016 – 2028 (USD Million)
Table 39 Europe stretch marks market, by product, 2016 – 2028 (USD Million)
Table 40 Europe scar treatment market, by end use, 2016 – 2028 (USD Million)
Table 41 Germany scar treatment market, by product, 2016 – 2028 (USD Million)
Table 42 Germany topical products market, by type, 2016 – 2028 (USD Million)
Table 43 Germany laser products market, by type, 2016 – 2028 (USD Million)
Table 44 Germany scar treatment market, by scar type, 2016 – 2028 (USD Million)
Table 45 Germany atrophic scar treatment market, by product, 2016 – 2028 (USD Million)
Table 46 Germany hypertrophic and keloid scar treatment market, by product, 2016 – 2028 (USD Million)
Table 47 Germany contracture scar treatment market, by product, 2016 – 2028 (USD Million)
Table 48 Germany stretch marks market, by product, 2016 – 2028 (USD Million)
Table 49 Germany scar treatment market, by end use, 2016 – 2028 (USD Million)
Table 50 U.K. scar treatment market, by product, 2016 – 2028 (USD Million)
Table 51 U.K. topical products market, by type, 2016 – 2028 (USD Million)
Table 52 U.K. laser products market, by type, 2016 – 2028 (USD Million)
Table 53 U.K. scar treatment market, by scar type, 2016 – 2028 (USD Million)
Table 54 U.K. atrophic scar treatment market, by product, 2016 – 2028 (USD Million)
Table 55 U.K. hypertrophic and keloid scar treatment market, by product, 2016 – 2028 (USD Million)
Table 56 U.K. contracture scar treatment market, by product, 2016 – 2028 (USD Million)
Table 57 U.K. stretch marks market, by product, 2016 – 2028 (USD Million)
Table 58 U.K. scar treatment market, by end use, 2016 – 2028 (USD Million)
Table 59 Spain scar treatment market, by product, 2016 – 2028 (USD Million)
Table 60 Spain topical products market, by type, 2016 – 2028 (USD Million)
Table 61 Spain laser products market, by type, 2016 – 2028 (USD Million)
Table 62 Spain scar treatment market, by scar type, 2016 – 2028 (USD Million)
Table 63 Spain atrophic scar treatment market, by product, 2016 – 2028 (USD Million)
Table 64 Spain hypertrophic and keloid scar treatment market, by product, 2016 – 2028 (USD Million)
Table 65 Spain contracture scar treatment market, by product, 2016 – 2028 (USD Million)
Table 66 Spain stretch marks market, by product, 2016 – 2028 (USD Million)
Table 67 Spain scar treatment market, by end use, 2016 – 2028 (USD Million)
Table 68 France scar treatment market, by product, 2016 – 2028 (USD Million)
Table 69 France topical products market, by type, 2016 – 2028 (USD Million)
Table 70 France laser products market, by type, 2016 – 2028 (USD Million)
Table 71 France scar treatment market, by scar type, 2016 – 2028 (USD Million)
Table 72 France atrophic scar treatment market, by product, 2016 – 2028 (USD Million)
Table 73 France hypertrophic and keloid scar treatment market, by product, 2016 – 2028 (USD Million)
Table 74 France contracture scar treatment market, by product, 2016 – 2028 (USD Million)
Table 75 France stretch marks market, by product, 2016 – 2028 (USD Million)
Table 76 France scar treatment market, by end use, 2016 – 2028 (USD Million)
Table 77 Italy scar treatment market, by product, 2016 – 2028 (USD Million)
Table 78 Italy topical products market, by type, 2016 – 2028 (USD Million)
Table 79 Italy laser products market, by type, 2016 – 2028 (USD Million)
Table 80 Italy scar treatment market, by scar type, 2016 – 2028 (USD Million)
Table 81 Italy atrophic scar treatment market, by product, 2016 – 2028 (USD Million)
Table 82 Italy hypertrophic and keloid scar treatment market, by product, 2016 – 2028 (USD Million)
Table 83 Italy contracture scar treatment market, by product, 2016 – 2028 (USD Million)
Table 84 Italy stretch marks market, by product, 2016 – 2028 (USD Million)
Table 85 Italy scar treatment market, by end use, 2016 – 2028 (USD Million)
Table 86 Russia scar treatment market, by product, 2016 – 2028 (USD Million)
Table 87 Russia topical products market, by type, 2016 – 2028 (USD Million)
Table 88 Russia laser products market, by type, 2016 – 2028 (USD Million)
Table 89 Russia scar treatment market, by scar type, 2016 – 2028 (USD Million)
Table 90 Russia atrophic scar treatment market, by product, 2016 – 2028 (USD Million)
Table 91 Russia hypertrophic and keloid scar treatment market, by product, 2016 – 2028 (USD Million)
Table 92 Russia contracture scar

Major Companies

  • Smith & Nephew PLC
  • Lumenis
  • Merz Pharmaceuticals, LLC
  • Sonoma Pharmaceuticals, Inc.
  • Cynosure
  • CCA Industries, Inc.
  • New medical Technology Inc.
  • Molnlycke Health Care AB
  • Suneva Medical

Major Segmentation

  • Product Outlook (Revenue, USD Million, 2016 – 2028)
  • Topical Products
      • Creams
      • Gels
      • Silicon Sheets
    • Others
  • Laser Products
      • CO2Laser
      • Pulse-dyed Laser
    • Others
    • Injectables
    • Others
  • Scar Type Outlook (Revenue, USD Million, 2016 – 2028)
    • Atrophic Scars
    • Hypertrophic and Keloid Scars
    • Contracture Scars
    • Stretch Marks
  • End-use Outlook (Revenue, USD Million, 2016 – 2028)
    • Hospitals
    • Clinics
    • Retail Pharmacies/ E-commerce

Why Choose MWR

Quality Research

Our goal is to provide high-quality data that stimulates growth and creates a win-win situations

Unlimited User Access 

We offer Corporate User license access on all our reports in which you can share the report with your entire team without any restrictions

Free Company Inclusion 

We give you an option to include 3-4 additional company players of your choice in our report without any extra charges

Post Sale Assistance

Unlimited post sales service with an account manager dedicated to making sure that all your needs are met

Covid-19 Impact Analysis

All our research report includes latest Covid-19 Impact and its analysis

Download Free Sample PDF

444 Alaska Avenue

Suite #BAA205 Torrance, CA 90503 USA

+1 424 360 2221

24/7 Customer Support

Download Free Sample PDF